NASDAQUtilitiesRegulated ElectricSnapshot 2026-08-31
Reading EXC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Warn: Management is running behind on a stated commitment.
Exelon plans to invest $41.7 billion over four years to improve infrastructure. It aims to earn $2.81 to $2.91 per share in 2026. The company has a low price-to-earnings ratio of 17.3, cheaper than peers. Earnings grew 2.2% above estimates in Q1 2026.
Regulatory challenges in Maryland could hurt future earnings. Capital spending may pressure cash flow. EPS growth near the top of 5-7% CAGR is uncertain with mixed management signals.
The market prices in about 4% revenue growth and values the stock slightly below our $48 fair value. Our view aligns with consensus but sees risks from regulatory and capital allocation challenges.
Breaks if: CAPEX plan falls materially below $41.7 billion over four years
Breaks if: EPS CAGR falls below 5% over 2025-2029
Exelon aims for EPS growth near the top end of a 5-7% compound annual growth rate from 2025 to 2029.
Breaks if: EPS falls below $2.81 in FY26
Maintain and deliver on the full year 2026 adjusted (non-GAAP) operating earnings guidance range of $2.81 to $2.91 per share.
Stated as a priority in 4 of last 4 quarters. Management affirmed the 2026 adjusted operating earnings guidance range of $2.81 to $2.91 per share consistently from 2025-Q4 through 2026-Q2. Adjusted operating earnings per share were $0.91 in 2026-Q1 and $0.43 in 2026-Q2, supporting the full-year guidance. The trajectory is delivering as management has maintained guidance and reported results in line with expectations.
“Affirming full year 2026 Adjusted (non-GAAP) operating earnings guidance range of $2.81-$2.91 per share”
“Affirming full year 2026 Adjusted (non-GAAP) operating earnings guidance range of $2.81-$2.91 per share”
“Introducing full year 2026 Adjusted (non-GAAP) operating earnings guidance range of $2.81-$2.91 per share”
“Affirming full year 2026 Adjusted (non-GAAP) operating earnings guidance range of $2.81-$2.91 per share”
Breaks if: Material negative regulatory ruling reduces earnings guidance
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on utility performance. The current thesis state is cautious, given the recent weak financial performance and mixed signals from management.
The market appears to have priced in a cheap valuation compared to peers, indicating low expectations for significant growth. However, there is a fragility in execution quality that could impact future performance.
Fundamentals are expected to remain stable in the near term, with management affirming earnings guidance and capital expenditure plans. However, recent financial results have been weak, which could pose risks to achieving future targets.
The thesis hinges on management's ability to maintain guidance and the performance of sector bellwethers like NEE, SO, and DUK. Any changes in their earnings or guidance could significantly impact EXC's trajectory.
Overall, the outlook for EXC over the next 1 to 3 years is cautious, with a need to monitor sector performance and management execution closely. Not investment advice.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. Exelon affirmed its full year EPS guidance. This is a positive sign for the company. However, it missed earnings expectations in the latest report. Regulatory hurdles may also impact future earnings guidance.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
